Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:57 PM
Ignite Modification Date:
2025-12-24 @ 4:57 PM
NCT ID:
NCT00199550
Eligibility Criteria:
Inclusion Criteria:
* Symptomatic benign prostatic hyperplasia including patients with acute urinary retention;
* Peak urinary flow rate \< 12 ml/sec;
* American Urological Association (AUA) symptom score \> 12.
Exclusion Criteria:
* Previous open or transurethral prostatic surgery;
* History of urethral stricture;
* Failure to discontinue alpha-adrenergic blocking agents for at least 14 days prior to surgery;
* Failure to discontinue 5-alpha reductase inhibitor for at least 1 month prior to surgery;
* Patient interested in future fertility;
* Patient with known neurogenic bladder dysfunction;
* Untreated urinary tract infection;
* American Society of Anesthesiologist (ASA) Class \>III;
* Patients requiring anticoagulation with Coumadin or Heparin;
* Patient unable or unwilling to comply with follow-up schedule.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
50 Years
Maximum Age:
85 Years
Study:
NCT00199550
Study Brief:
Protocol Section:
NCT00199550